November 8, 2019,
Preclinapps attends BioFIT 2019 conference in Marseille, France on 10-11 Decembe...



MedRod delivers active ingredient in efficient and reliable manner to support and improve the quality of preclinical studies
Stable and reliable and cost-effective substitute to chronic injections.

What is MedRod
- typically 1-4 mm diameter, 3 - 10 mm long cylinder shaped elastic rod
- size is dependable on the potency of substance, study type and duration of the study
- can be used for stable release subcutaneously (s.c) or orthotopically
- optimal for steroidal and hydrophobic substances
- dose range 0.02 mcg/day up to 200 mcg/day
- validated products: Estrone (E1), Estradiol (E2), Dihydrotestosterone (DHT), Testosterone (TE)

Benefits of MedRod
- Adjustable sustained drug release from weeks to several months
- Utilizes biocompatible, biostable soft matrix that remains unchanged in tissue
- Small size and soft nature of MedRod minimizes irritation and makes it easy to assemble subcutaneously
- Removable at any time of the study, if sudden termination or adjustment of drug delivery desired
- No replacement required during long-lasting studies compared to many other substance releasing devices and methods
- Save time and money by eliminating the need of frequent animal handling
- Decreases suffering and animal number to be used in the studies, thus follows 3R principle
(Replacement, Reduction, Refinement)

Company brochureCompany brochure

If you are interested in test samples for your study, email to: info[at]preclinapps.com

7 February, 2017

About Us
Research Applications
Contact Us
65766  | Copyright © 2019 PreclinApps Ltd   
Web dev. Webbinen.net